Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Brain Research|February 20, 2010
Effect of immunomodulatory medication on regional gray matter loss in relapsing-remitting multiple sclerosis--a longitudinal MRI studyKerstin Bendfeldt, Hanspeter Egger, Thomas E Nichols, et al.Biological Psychiatry|July 1, 2008
Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibitionStefan J Borgwardt, Paul Allen, Sagnik Bhattacharyya, et al.Neuropsychobiology|March 7, 2018
Epigenetic Effects of Intravenous Diacetylmorphine on the Methylation of POMC and NR3C1Adrian Groh, Mathias Rhein, Vanessa Buchholz, et al.Archives of General Psychiatry|January 7, 2009
Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processingPaolo Fusar-Poli, José A Crippa, Sagnik Bhattacharyya, et al.Neuroimage|November 18, 2008
Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - A longitudinal voxel-based morphometry studyKerstin Bendfeldt, Pascal Kuster, Stefan Traud, et al.Journal of Psychiatry & Neuroscience : JPN|February 11, 2014
Abnormal effective connectivity and psychopathological symptoms in the psychosis high-risk stateAndré Schmidt, Renata Smieskova, Andor Simon, et al.Neuroimage. Clinical|June 26, 2015
Hippocampal volume correlates with attenuated negative psychotic symptoms irrespective of antidepressant medicationRaffaele Bernasconi, Renata Smieskova, André Schmidt, et al.Biological Psychiatry|November 14, 2006
Regional gray matter volume abnormalities in the at risk mental stateStefan J Borgwardt, Anita Riecher-Rössler, Paola Dazzan, et al.Human Brain Mapping|January 29, 2010
Spatiotemporal distribution pattern of white matter lesion volumes and their association with regional grey matter volume reductions in relapsing-remitting multiple sclerosisKerstin Bendfeldt, Jan Ole Blumhagen, Hanspeter Egger, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 18, 2011
Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI studyToby T Winton-Brown, Paul Allen, Sagnik Bhattacharyya, et al.Pageof 4